These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24934553)

  • 21. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals.
    Schulz KF; Chalmers I; Grimes DA; Altman DG
    JAMA; 1994 Jul; 272(2):125-8. PubMed ID: 8015122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of randomisation method use in RCTs and association of trial design characteristics with method selection.
    Bruce CL; Juszczak E; Ogollah R; Partlett C; Montgomery A
    BMC Med Res Methodol; 2022 Dec; 22(1):314. PubMed ID: 36476324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRINI: random group allocation of multiple prognostic factors.
    Kasturi J; Geisler JG; Liu J; Kirchner T; Amaratunga D; Lubomirski M
    Contemp Clin Trials; 2011 May; 32(3):372-81. PubMed ID: 21187163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Shiny Balancer - software and imbalance criteria for optimally balanced treatment allocation in small RCTs and cRCTs.
    Grischott T
    BMC Med Res Methodol; 2018 Oct; 18(1):108. PubMed ID: 30326827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An easily customized, random allocation system using the minimization method for multi-institutional clinical trials.
    Kenjo Y; Antoku Y; Akazawa K; Hanada E; Kinukawa N; Nose Y
    Comput Methods Programs Biomed; 2000 May; 62(1):45-9. PubMed ID: 10699684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MACT: a manageable minimization allocation system.
    Cui Y; Bu H; Wang H; Liao S
    Comput Math Methods Med; 2014; 2014():645064. PubMed ID: 24701251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a balancing procedure in multicenter clinical trials. Simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants.
    Rovers MM; Straatman H; Zielhuis GA; Ingels K; van der Wilt GJ
    Int J Technol Assess Health Care; 2000; 16(1):276-81. PubMed ID: 10815372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are randomised controlled trials involving adenotonsillectomy well reported?
    Ifeacho S; Ajayi O; Hannan SA
    Int J Pediatr Otorhinolaryngol; 2011 Jul; 75(7):939-42. PubMed ID: 21596447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The "best balance" allocation led to optimal balance in cluster-controlled trials.
    de Hoop E; Teerenstra S; van Gaal BG; Moerbeek M; Borm GF
    J Clin Epidemiol; 2012 Feb; 65(2):132-7. PubMed ID: 21840173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.
    Schulz KF; Grimes DA; Altman DG; Hayes RJ
    BMJ; 1996 Mar; 312(7033):742-4. PubMed ID: 8605459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction.
    Hills RK; Gray R; Wheatley K
    J Evid Based Med; 2009 Aug; 2(3):196-204. PubMed ID: 21349013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Well-conducted randomisation will improve balance and reliability of treatment estimates: Randomised controlled trials: random acts of allocation.
    Allotey J; Marlin N
    BJOG; 2019 Sep; 126(10):1287. PubMed ID: 31222851
    [No Abstract]   [Full Text] [Related]  

  • 35. A flexible random allocation program for multi-institutional clinical trials.
    Odaka T; Akazawa K; Watanabe Y; Nose Y; Ogura H
    J Med Syst; 1994 Feb; 18(1):39-53. PubMed ID: 8064207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of unequal randomisation in clinical trials--An update.
    Peckham E; Brabyn S; Cook L; Devlin T; Dumville J; Torgerson DJ
    Contemp Clin Trials; 2015 Nov; 45(Pt A):113-22. PubMed ID: 26027788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodological reporting quality of randomized controlled trials: A survey of seven core journals of orthopaedics from Mainland China over 5 years following the CONSORT statement.
    Zhang J; Chen X; Zhu Q; Cui J; Cao L; Su J
    Orthop Traumatol Surg Res; 2016 Nov; 102(7):933-938. PubMed ID: 27514437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor reporting quality of key Randomization and Allocation Concealment details is still prevalent among published RCTs in 2011: a review.
    Clark L; Schmidt U; Tharmanathan P; Adamson J; Hewitt C; Torgerson D
    J Eval Clin Pract; 2013 Aug; 19(4):703-7. PubMed ID: 23648066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.
    Avins AL
    J Med Ethics; 1998 Dec; 24(6):401-8. PubMed ID: 9873981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cluster randomised trials.
    Barbui C; Cipriani A
    Epidemiol Psychiatr Sci; 2011 Dec; 20(4):307-9. PubMed ID: 22201207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.